Consistently, we observed that NAP1L1 expression level was much lower in CD34− AML cells than CD34+ LSCs freshly isolated from AML patients (Figure 5M), so as in the differentiated cells compared with the parent NB4 cells (Figure S4B, Supporting Information). The gene discussed is NAP1L1; the disease is acute myeloid leukemia.